LOTTE BIOLOGICS

Newsroom

Delivering the latest news
from LOTTE BIOLOGICS

Key visual

MOU April 26, 2023

LOTTE BIOLOGICS USA Signs LOI with Merck MilliporeSigma

 

LOTTE BIOLOGICS USA (LLC) signed a Letter of Intent (LOI) for preferred supplier nomination with MilliporeSigma to reinforce their business partnership. Through this commitment, LOTTE BIOLOGICS USA has designated MilliporeSigma as a preferred supplier for the expansion of its manufacturing plant and intends to enhance the cooperative relationship between the two companies in areas such as training and technical support.